Hangzhou Coco Healthcare Products Co.,Ltd. announced that it has received CNY 150 million in a round of funding from new investor, ARIA Investment Partners IV L.P., a fund managed by CLSA Capital Partners on May 11, 2015.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.55 CNY | -3.33% |
|
-2.71% | -29.17% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.17% | 289M | |
+15.69% | 46.97B | |
+2.63% | 19.43B | |
+3.08% | 3.61B | |
+18.76% | 3B | |
+57.65% | 1.39B | |
-27.20% | 1.36B | |
+13.83% | 922M | |
+10.85% | 721M | |
+25.94% | 433M |
- Stock Market
- Equities
- 301009 Stock
- News Hangzhou Coco Healthcare Products Co.,Ltd.
- Hangzhou Coco Healthcare Products Co.,Ltd. announced that it has received CNY 150 million in funding from CLSA Capital Partners.